4502:TYO
Takeda Pharmaceutical Co Ltd
Â¥5,969.00
arrow_upward
+1.43%(+84.00) 1D
Sep 25, 3:30:00 PM GMT+9 · JPY
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4502...
Open
Â¥5,930
High
Â¥5,996
Low
Â¥5,903
Mkt. cap
9.56T
Avg. vol.
4.03M
Volume
3.83M
Dividend
3.35%
Quarterly dividend
Â¥50
Ex-dividend date
Sep 29, 2026
52-wk high
Â¥6,033
52-wk low
Â¥4,102
EPS
-Â¥103
Shares outstanding
784.48M
No. of employees
47K
Open
Â¥5,930
High
Â¥5,996
Low
Â¥5,903
Mkt. cap
9.56T
Avg. vol.
4.03M
Volume
3.83M
Dividend
3.35%
Quarterly dividend
Â¥50
Ex-dividend date
Sep 29, 2026
52-wk high
Â¥6,033
52-wk low
Â¥4,102
EPS
-Â¥103
Shares outstanding
784.48M
No. of employees
47K
Profile
The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company. It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue. The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States. As of 2015, Christophe Weber was appointed as the CEO and president of Takeda. In 2026, Julie Kim was noted in a news item as "CEO-elect". Wikipedia
About Takeda Pharmaceutical Co Ltd
CEOChristophe Weber | Christophe Weber
Employees47K
FoundedJun 12, 1781
Headquarters-
SectorPharmaceutical industry
Websitetakeda.com